Search
Search Results
##search.searchResults.foundPlural##
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
4019PDF: 1712HTML: 8277Randi Fig: 240 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1718PDF: 1117HTML: 156 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1555PDF: 970HTML: 10134cover letter to the editor: 227tile page: 308 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1845PDF: 1181HTML: 201 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1491PDF: 1151HTML: 493 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2514PDF: 1097HTML: 2250 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3825PDF: 1247HTML: 23398 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2731PDF: 1045HTML: 400 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1841PDF: 1164HTML: 6578original file with images: 347 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3095PDF: 1373HTML: 2856Figure 1: 239 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7304PDF: 3878HTML: 864 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4742PDF: 1607HTML: 8565 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1313PDF: 964HTML: 313 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1440PDF: 975HTML: 1215Coverletter: 306 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
687PDF: 677Suppl. Files: 97HTML: 179 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1510PDF: 667HTML: 4208 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2116PDF: 1147HTML: 285 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3502PDF: 1658HTML: 570 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1739PDF: 999HTML: 417 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4470PDF: 2140HTML: 1981 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
899PDF: 608HTML: 4055 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1738PDF: 1268HTML: 463Suppl. Figure: 234Suppl. Tables: 264 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2967PDF: 1064HTML: 4762 -







